Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non Interventional Longitudinal Study To Assess The Acceptability And The Satisfaction Of Patients With Haemophilia A Treated Both On Demand And On Prophylaxis With A New Factor Viii Delivery System Fusengo

NCT01959919 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT01959919
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01959919 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non Interventional Longitudinal Study To Assess The Acceptability And The Satisfaction Of Patients With Haemophilia A Treated Both On Demand And On Prophylaxis With A New Factor Viii Delivery System Fusengo
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
January 27, 2014
Completion date
December 12, 2016
Enrollment
86 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia a